Zusammenfassung
Das Fach Radiologie hat in der Medizin eine Sonderstellung erlangt. Eine exakte Diagnose ist entscheidend, um rasch und effizient behandeln zu können. Dies wirkt sich direkt auf den einzelnen Patienten aus, was mit einer Verkürzung der Zeit bis zur Diagnosestellung, dem Vermeiden unnötiger invasiver Methoden oder teuren zeitaufwendigen Verlaufskontrollen einhergeht. Die MRT stellt aufgrund ihrer kontinuierlichen Entwicklungen der letzten Jahre ein Musterbeispiel dar, v. a. bei der Diagnostik der verschiedenen Lebererkrankungen. In diesem Artikel erläutern wir den direkten Zusammenhang zwischen neueren technischen Entwicklungen im Bereich der MRT wie 3,0 T, diffusionsgewichteten Sequenzen, Perfusions-MRT, Spektroskopie, Texturanalyse sowie MR-Elastographie und dem Stellen einer sicheren, nichtinvasiven Diagnose der fokalen und diffusen Leberveränderungen.
Abstract
Radiology has gained an exceptional position in medicine because a correct diagnosis is the most crucial issue in determining an accurate and personalized therapeutic strategy. This has a direct influence not only on the individual patient but also on the socio-economic aspects of healthcare services in terms of shortening the time interval to establish a diagnosis and to avoid risk-associated invasive diagnostic methods or long-term, cost-intensive follow-up. Magnetic resonance imaging (MRI) is an excellent example of this which due to continuous technological developments and emerging techniques allows a non-invasive diagnosis of the different hepatic diseases. In this article, we illustrate the direct correlation between the recent technical advances in MRI, such as 3.0 T, diffusion-weighted imaging, perfusion imaging, spectroscopy, texture analysis and MR elastography and obtaining a confident non-invasive diagnosis of focal and diffuse liver diseases.
Literatur
Annet L, Peeters F, Abarca-Quinones J et al (2007) Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 25:122–128
Ba-Ssalamah A, Happel B, Kettenbach J et al (2004) MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents. Radiologe 44:1170–1184
Ba-Ssalamah A, Uffmann M, Saini S et al (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19:342–357
Barth MM, Smith MP, Pedrosa I et al (2007) Body MR imaging at 3.0 T: understanding the opportunities and challenges. Radiographics 27:1445–1462; discussion 1462–1444
Chang KJ, Kamel IR, Macura KJ et al (2008) 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics 28:1983–1998
Chernyak V, Kim J, Rozenblit AM et al (2011) Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors. J Magn Reson Imaging. DOI 10.1002/jmri.22635
Choe KA, Smith RC, Wilkens K et al (1997) Motion artifact in T2-weighted fast spin-echo images of the liver: effect on image contrast and reduction of artifact using respiratory triggering in normal volunteers. J Magn Reson Imaging 7:298–302
Choi JY, Choi JS, Kim MJ et al (2010) Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 31:571–578
De Bazelaire CM, Duhamel GD, Rofsky NM et al (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230:652–659
Faria SC, Ganesan K, Mwangi I et al (2009) MR imaging of liver fibrosis: current state of the art. Radiographics 29:1615–1635
Fischbach F, Bruhn H (2008) Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int 28:297–307
Fischbach F, Thormann M, Ricke J (2004) (1) H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla. Radiologe 44:1192–1196
Fruehwald-Pallamar J, Bastati-Huber N, Fakhrai N et al (2011) Confident non-invasive diagnosis of pseudolesions of the liver using diffusion-weighted imaging at 3T MRI. Eur J Radiol, in press
Hagiwara M, Rusinek H, Lee VS et al (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging – initial experience. Radiology 246:926–934
Holzapfel K, Breitwieser C, Prinz C et al (2007) Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA. Preliminary experience and clinical applications. Radiologe 47:536–544
Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458–466
Kim KA, Herigault G, Kim MJ et al (2011) Three-dimensional contrast-enhanced hepatic MR imaging: comparison between a centric technique and a linear approach with partial Fourier along both slice and phase directions. J Magn Reson Imaging 33:160–166
Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging – correlation with molecular transporters and histopathologic features. Radiology 256:817–826
Mayerhoefer ME, Schima W, Trattnig S et al (2010) Texture-based classification of focal liver lesions on MRI at 3.0 Tesla: a feasibility study in cysts and hemangiomas. J Magn Reson Imaging 32:352–359
Merkle EM, Dale BM (2006) Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 186:1524–1532
Mullins PG, Chen H, Xu J et al (2008) Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites. Magn Reson Med 60:964–969
Nilsson H, Nordell A, Vargas R et al (2009) Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 29:1323–1331
Pagani E, Bizzi A, Di Salle F et al (2008) Basic concepts of advanced MRI techniques. Neurol Sci 29(Suppl 3):290–295
Qayyum A (2009) MR spectroscopy of the liver: principles and clinical applications. Radiographics 29:1653–1664
Salameh N, Peeters F, Sinkus R et al (2007) Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 26:956–962
Schmid-Tannwald C, Reiser MF, Zech CJ (2011) Diffusion-weighted magnetic resonance imaging of the abdomen. Radiologe 51:195–204
Seo HJ, Kim MJ, Lee JD et al (2011) Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Invest Radiol, in press
Tamrazi A, Vasanawala SS (2011) Functional hepatobiliary MR imaging in children. Pediatr Radiol, in press
Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47–66
Tschirch FT, Struwe A, Petrowsky H et al (2008) Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 18:1577–1586
Tsuda N, Okada M, Murakami T (2010) New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 73:137–142
Wang Y, Al Kasab TK, Narin O et al (2011) Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology, in press
Watanabe H, Kanematsu M, Goshima S et al (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging – preliminary observations. Radiology 259:142–150
Yopp AC, Schwartz LH, Kemeny N et al (2011) Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Ann Surg Oncol, in press
Zech CJ, Herrmann KA, Dietrich O et al (2008) Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 43:261–266
Zech CJ, Herrmann KA, Huber A et al (2004) High-resolution MR-imaging of the liver with T2-weighted sequences using integrated parallel imaging: comparison of prospective motion correction and respiratory triggering. J Magn Reson Imaging 20:443–450
Zech CJ, Schoenberg SO, Herrmann KA et al (2004) Modern visualization of the liver with MRT. Current trends and future perspectives. Radiologe 44:1160–1169
Zho SY, Park J, Choi JY et al (2010) Respiratory motion compensated MR cholangiopancreatography at 3.0 Tesla. J Magn Reson Imaging 32:726–732
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bastati-Huber, N., Prosch, H., Baroud, S. et al. Neuere Entwicklungen der Leber-MRT. Radiologe 51, 680–687 (2011). https://doi.org/10.1007/s00117-010-2126-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-010-2126-2